TuHURA Biosciences, Inc.
Mike Krsulich currently serves as the Head of Quality Assurance (GxP) at TuHURA Biosciences, Inc., having joined the company in August 2024. Previously, Mike held the position of Head of Global Quality Assurance (GMP/GLP) at Reaction Biology from January 2023 to July 2024. Mike's extensive experience in quality assurance includes roles as Senior Director of GxP Quality Assurance at Renovacor, where the company was acquired by Rocket Pharmaceuticals, and Senior Director of GMP Quality Assurance at Galera Therapeutics, Inc. Additionally, Mike worked at Teva Pharmaceuticals as Associate Director of Product Quality Assurance and held various positions at Eisai US, including Senior Manager of Development Quality Assurance. Earlier career highlights include roles at OPK Biotech, LLC, Globus Medical, WuXi AppTec, and McNeil Consumer Healthcare. Mike Krsulich earned a Bachelor of Science degree in Psychology and Biology/Chemistry from the University of Pittsburgh.
This person is not in any teams
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.